Last reviewed · How we verify
NCT07148609
Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients.
NA trial testing Video game-facilitated group activity in Schizophrenia Patients in 64 participants. Participants enrolled and being followed up; not accepting new ones.
31 March 2026
Quick facts
| Lead sponsor | TsaoTun Psychiatric Center, Department of Health, Taiwan |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 64 |
| Start date | 3 May 2025 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Video game-facilitated group activity
Conditions studied
- Schizophrenia Patients — all drugs for Schizophrenia Patients →
Sponsor
TsaoTun Psychiatric Center, Department of Health, Taiwan
Who can join
Adults 20 to 65, any sex, with Schizophrenia Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if video game-facilitated group activity helps to improve the quality of life and social function in inpatients with chronic schizophrenia. The main questions it aims to answer are: * Does video game-facilitated group activity enhance the quality of life as measured by a standardized scale (WHOQOL) in patients with schizophrenia hospitalized in a psychiatric hospital? * Can video game-facilitated group activity promote social function as measured by a specific scale (PSP) in patients with schizophrenia hospitalized in a psychiatric hospital? Researchers will compare video game-facilitated group activity to regular occupational therapy to see if the intervention is beneficial to patients with chronic schizophrenia. Participants will: * Attend to video game-facilitated group activity or regular occupational therapy three times a week for 12 weeks. * Receive assessments upon and after the 12-week intervention, and another 12 weeks after the intervention ends.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07148609
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophrenia Patients
Currently open trials in the same condition.
- NCT06740747 — Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia · NA · recruiting
Other TsaoTun Psychiatric Center, Department of Health, Taiwan trials
Trials by the same sponsor.
- NCT06960265 — Effects of Repetitive Transcranial Magnetic Stimulations in Patients With Amphetamine Use Disorders · NA · not yet recruiting
- NCT06502509 — Kombucha Tea for Improving Defecation in Patients With Schizophrenia- a Randomized Controlled Study · NA · completed
- NCT05948696 — Experience of Horticultural Group Therapy Among People With Chronic Schizophrenia · unknown
- NCT03552237 — Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients · NA · unknown
- NCT03152032 — Employment Outcomes After Vocational Training · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07148609 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TsaoTun Psychiatric Center, Department of Health, Taiwan
- Last refreshed: 29 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07148609.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing